Should you buy Challenger Ltd?

Challenger Ltd (ASX:CGF) is a complex business to analyse.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It hasn't been a particularly great year for shareholders of annuity provider Challenger Ltd (ASX: CGF) with the share price falling around 7% in the past 12 months.

That's worse than the one-year return from the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) which has gained nearly 2.5% and certainly worse than many of Challenger's peer group, such as AMP Limited (ASX: AMP) which is up over 15% and IOOF Holdings Limited (ASX: IFL) which has gained around 27%.

Despite the recent lacklustre performance there are reasons to look favourably on Challenger's future. Here are some of the positives:

With an increasing number of Australians moving into the retirement phase of their life, securing an income to cover essential living costs is of the utmost importance. Annuities – which are a core product for Challenger – offer a solution to retirees and self-managed superannuation fund (SMSF) trustees by providing an income that remains for the whole of an account holder's life.

Annuities have obvious appeal within the superannuation system and Challenger is the leading provider of these products. To date, annuities have for the most part remained a marginal product however they are increasingly becoming mainstream thanks to Challenger's marketing and education to investors of the benefit of annuities.

Investor access to investment products on 'platforms' is vitally important. The increasing availability of Challenger's annuity products on platforms is a critical development. Platform representation will shortly expand substantially when Challenger launches on the Commonwealth Bank of Australia (ASX: CBA)-owned Colonial First State FirstChoice platform.

But there are also negatives

Despite the annuity business offering exposure to an enticing thematic, there are reasons to be cautious about buying shares in Challenger.

Analysing and developing a knowledgeable understanding of the risks and liabilities in the annuities business is a necessary task but arguably it is beyond the capabilities of many investors.

Accurately evaluating a business should be a key step in any investment process but unfortunately valuing Challenger's business is complex and may be best off relegated to the 'too hard' basket.

As Buffett has famously counselled investors, staying within your 'circle of competence' can lead to better investment returns in the long term.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »